BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  QLT Inc. Announces Positive Preliminary Results From Phase 1b Retreatment Trial Of QLT091001 In Subjects With Leber Congenital Amaurosis And Retinitis Pigmentosa Due To Mutations In LRAT Or RPE65

  February 27, 2014

   · 

  1 min read
• ALK-Abello A/S Participates In The Credit Suisse 2014 London Healthcare Conference

  February 27, 2014

   · 

  1 min read
• Prima Biomed To Present At Regen Med Investor Day March 26th In New York

  February 27, 2014

   · 

  2 min read
• BioLight Life Sciences To Present At 26th Annual ROTH Conference

  February 27, 2014

   · 

  1 min read
• Pharm Country

  MYOS Initiates Clinical Study Of MYO-T12(R) In Adult Women

  February 27, 2014

   · 

  7 min read
• Biotech Beach

  Neurocrine Biosciences, Inc. Prices Public Offering Of Common Stock

  February 27, 2014

   · 

  3 min read
• BioMidwest

  Camargo Pharmaceutical Services Release: CEOs Say 505(b)(2) Pathway Will Drive Growth In Generic Industry

  February 27, 2014

   · 

  1 min read
• Drug Development

  FDA Grants Astellas Qualified Infectious Disease Product Designation For Isavuconazole For The Treatment Of Invasive Mucormycosis

  February 27, 2014

   · 

  2 min read
• Biotech Beach

  Ignyta Announces Submission Of IND For RXDX-101

  February 27, 2014

   · 

  1 min read
• Drug Development

  Provectus Pharmaceuticals Inc. Melanoma Version Of PV-10 Completes Phase 2 And Is Prepping For BTD

  February 27, 2014

   · 

  4 min read